IP Library Granted Patent US 7,090,681
Granted Patent B2
US 7,090,681 · App. 10/666,872 · Granted Aug 15, 2006

Methods and apparatus for delivery of ocular implants

Assignee: Allergan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,090,681
App. No.
10/666,872
Granted
Aug 15, 2006
Kind
B2
Abstract

An apparatus and methods for delivering ocular implants or microimplants. The apparatus is ergonomically designed for ease of use, and a simple manual depression of an actuator produces proportional movement of a linkage causing the implant or microimplant to be ejected through a cannula disposed at the desired location in the eye. Small gauge cannulas are provided for self-sealing methods of delivery.

Claims (9)

1. An apparatus for implanting an ocular implant at a location in a patient's eye comprising:

a cannula having a lumen extending therethrough configured to receive an ocular implant; and

means for retaining an implant received within the cannula lumen to minimize inadvertent release of the implant from the cannula wherein the retention means comprises a frictional stop which extends into the cannula lumen for contacting an implant received therein, wherein the frictional stop comprises an O-ring, at least a portion of which extends into the cannula lumen for contacting an implant received therein, wherein the cannula includes a notch, the notch providing for communication between the cannula lumen and cannula exterior, and wherein the O-ring is positioned around the cannula and where a portion of the O-ring is received in the notch and extends into the cannula lumen.

2. The apparatus of claim 1 wherein the cannula includes a notch, the notch providing for communication between the cannula lumen and cannula exterior, and wherein the frictional stop comprises tubing positioned around the cannula and where a portion of the tubing is received in the notch and extends into the lumen.

3. The apparatus of claim 1 wherein the frictional stop comprises a spring mechanism.

4. The apparatus of claim 1 wherein the frictional stop is integral to the cannula.

5. The apparatus of claim 1 wherein the retention means comprises a biocompatible adhesive for adhering the implant to the lumen.

6. The apparatus of claim 1 wherein the retention means comprises a frictional coating applied to the cannula lumen.

7. The apparatus of claim 1 wherein the retention means comprises a breakable membrane deployed within the cannula lumen.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2004
From: WEBER, DAVID A.; KANE, INGRID; REHAL, MIKE; LATHROP, ROBERT L., III; ETTER, JEFFREY; APTEKAREV, KENNY
To: ALLERGAN, INC.
Reel/Frame 015002/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2004
From: OCULEX PHARMACEUTICALS, INC.
To: ALLERGAN, INC.
Reel/Frame 014875/0513 →
Continuity (4)
Continuation In Part 1024688400 · Sep 18, 2002
Provisional Application 6049557000 · Aug 15, 2003
Provisional Application 6048669000 · Jul 11, 2003
Related Publication 20050101967A1 · May 12, 2005